Skip to main content

Table 5 Other postoperative evaluations of the ERAS and control groups

From: Analgesia and patient comfort after enhanced recovery after surgery in uvulopalatopharyngoplasty: a randomised controlled pilot study

 

ERAS Group

(n = 59)

Control Group

(n = 36)

P value

Postoperative symptoms(n(%))

 Dizziness

8(13.56%)

10(27.78%)

0.086

 Nausea and vomiting

1(1.69%)

4(11.11%)

0.046

 Pruritus

5(8.47%)

3(8.33%)

0.981

Riker sedation-agitation score (median(IQR))

 30 min after surgery

4(4–4)

4(3–4)

<0.001

 6 h after surgery

4(4–4)

4(4–4)

0.869

 12 h after surgery

4(4–4)

4(4–4)

1.000

 24 h after surgery

4(4–4)

4(4–4)

1.000

 48 h after surgery

4(4–4)

4(4–4)

1.000

Ramsay sedation score (median(IQR))

 30 min after surgery

2(2–2)

2(2–2)

0.221

 6 h after surgery

2(2–2)

2(2–2)

1.000

 12 h after surgery

2(2–2)

2(2–2)

1.000

 24 h after surgery

2(2–2)

2(2–2)

1.000

 48 h after surgery

2(2–2)

2(2–2)

1.000

Water swallow test score (median(IQR))

 6 h after surgery

2(2–2)

2(2–4)

0.009

 24 h after surgery

2(2–2)

2(2–4)

0.017

 48 h after surgery

2(2–2)

2(2–2)

0.464

  1. ERAS Enhanced recovery after surgery, VAS Visual analogue scale, IQR Interquartile range